Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,200 | -36,600 | -62,100 | 79,000 | 60,100 |
| Depreciation Amortization | 40,200 | 25,600 | 12,700 | 45,600 | 34,000 |
| Income taxes - deferred | 1,800 | 700 | -800 | 5,300 | 2,800 |
| Accounts receivable | 3,000 | 4,400 | 2,700 | -4,800 | -9,300 |
| Other Working Capital | 79,700 | 56,100 | 66,700 | -100 | -39,900 |
| Other Operating Activity | 22,300 | 19,200 | 18,000 | 17,100 | 18,000 |
| Operating Cash Flow | $122,800 | $69,400 | $37,200 | $142,100 | $65,700 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 1,700 |
| PPE Investments | -19,300 | -12,300 | -3,400 | -31,900 | -20,500 |
| Net Acquisitions | -129,800 | -119,800 | -122,700 | -33,200 | -28,000 |
| Purchase Of Investment | -1,000 | -600 | -200 | -4,400 | -3,400 |
| Purchase Sale Intangibles | -8,500 | -7,100 | -6,100 | -6,600 | -4,600 |
| Other Investing Activity | -8,500 | -7,100 | -6,100 | -7,400 | -4,600 |
| Investing Cash Flow | $-158,600 | $-139,800 | $-132,400 | $-76,900 | $-54,800 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | -1,100 |
| Debt Issued | 200,000 | 157,100 | 128,300 | 333,400 | 270,300 |
| Debt Repayment | -182,500 | -98,200 | -50,300 | -337,400 | -233,200 |
| Common Stock Issued | 23,200 | 19,100 | 8,400 | 36,600 | 29,200 |
| Common Stock Repurchased | -33,500 | -26,500 | -14,700 | -49,400 | -49,400 |
| Other Financing Activity | -1,800 | -1,500 | 0 | -4,400 | -4,400 |
| Financing Cash Flow | $5,400 | $50,000 | $71,700 | $-21,200 | $11,400 |
| Exchange Rate Effect | 300 | -700 | 300 | -17,100 | -18,200 |
| Beginning Cash Position | 61,100 | 61,100 | 61,100 | 34,200 | 34,200 |
| End Cash Position | 31,000 | 40,000 | 37,900 | 61,100 | 38,300 |
| Net Cash Flow | $-30,100 | $-21,100 | $-23,200 | $26,900 | $4,100 |
| Free Cash Flow | |||||
| Operating Cash Flow | 122,800 | 69,400 | 37,200 | 142,100 | 65,700 |
| Capital Expenditure | -22,800 | -14,900 | -6,000 | -37,900 | -26,100 |
| Free Cash Flow | 100,000 | 54,500 | 31,200 | 104,200 | 39,600 |